Alzheimer's Endpoint ADAS-Cog Likely Here To Stay Despite Clinical Failures

Gold standard outcome for Alzheimer's trials may have its difficulties, especially with rater error, but experts say there's no proven alternative to ADAS-cog.

Neurons and nervous system. 3d render of nerve cells

More from Clinical Trials

More from R&D